Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of sildenafil effect on lung tumor perfusion in NSCLC
NL-OMON19896Recruiting
- Sponsor
- Prof. Dr. E.F. Smit [email protected]
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sildenafil in non-small cell lung cancer (NSCLC), sponsored by Prof. Dr. E.F. Smit [email protected]. Primary endpoint: Change in tumor perfusion after sildenafil. Started Dec 2007; status: recruiting.
02
Drugs
sildenafil
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NL-OMON19896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON19896.